289 Heart Rate Variability in Opioid Use Disordered Participants Undergoing Buprenorphine-Assisted Detoxification

289 Heart Rate Variability in Opioid Use Disordered Participants Undergoing Buprenorphine-Assisted Detoxification

OBJECTIVES/GOALS: This study explored whether gabapentin (GBN) differentially impacted heart rate variability (HRV) and whether HRV was associated with opioid withdrawal ratings among participants with opioid use disorder (OUD) undergoing a randomized, double blind placebo-controlled, trial (RCT) of...

Full description

Bibliographic Details
Main Authors:	Lauren Russell, Jackson Weaver, Michael Mancino, Merideth Addicott, Linda Larson-Prior, Alison Oliveto
Format:	Article
Language:	English
Published:	Cambridge University Press 2023-04-01
Series:	Journal of Clinical and Translational Science
Online Access:	https://www.cambridge.org/core/product/identifier/S205986612300345X/type/journal_article

Similar Items

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
by: Hassan Ziaaddini, et al.
Published: (2018-12-01)

Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Opioid-Dependents
by: Hassan Ziaaddini, et al.
Published: (2012-12-01)

484 A Preliminary Study on the Pharmacodynamics of Oral Cannabis Ingestion in Older Adults
by: Lauren Russell, et al.
Published: (2024-04-01)

Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan
by: Tatsushi Nagano, et al.
Published: (2020-12-01)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023-12-01)

Sleep problems in opioid dependent patients maintained on buprenorphine
by: R. Tripathi, et al.
Published: (2021-04-01)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
by: H. Elarabi, et al.
Published: (2022-06-01)

A Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Heroin-Dependents and the Following Maintenance Treatment
by: Hasan Ziaaddini, et al.
Published: (2010-01-01)

Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects.
by: Christina M Larson, et al.
Published: (2024-01-01)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
by: Megan K Reed, et al.
Published: (2022-12-01)

Management of opioid addiction with buprenorphine: French history and current management
by: Poloméni P, et al.
Published: (2014-03-01)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
by: Hannah Shadowen, et al.
Published: (2022-12-01)

Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024-01-01)

An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine
by: Leana J. Pande, et al.
Published: (2023-10-01)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
by: Julia Tobacyk, et al.
Published: (2023-04-01)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
by: Celine M. Laffont, et al.
Published: (2022-11-01)

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
by: Connock, M, et al.
Published: (2007)

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
by: Connock, M, et al.
Published: (2007)

Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation
by: Connock, M, et al.
Published: (2007)

Relapse Rate after Opioid Detoxification in Drug Addict Patients
by: Beenish Gul, et al.
Published: (2022-06-01)

A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
by: James C. Miller, et al.
Published: (2023-11-01)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
by: Icro Maremmani, et al.
Published: (2023-08-01)

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
by: Christian Heidbreder, et al.
Published: (2023-03-01)

The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews
by: Pietro Scurti, et al.
Published: (2023-08-01)

Post-operative Analgesia in Opioid Dependent Patients: Comparison of ‎Intravenous Morphine and Sublingual Buprenorphine
by: Shaabanali Alizadeh, et al.
Published: (2015-01-01)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
by: Adams K. K., et al.
Published: (2022-10-01)

Comentarios sobre 289 mastopatias
by: Bernardo Botero Peláez, et al.
Published: (1958-10-01)

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder
by: R. Kathryn McHugh, et al.
Published: (2024-06-01)

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder
by: Michelle Eglovitch, et al.
Published: (2023-09-01)

Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder
by: Arnt F. A. Schellekens, et al.
Published: (2021-08-01)

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
by: Deborah C. Mash, et al.
Published: (2018-06-01)

Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
by: Xing Rong Guo, et al.
Published: (2019-09-01)

Long-term detoxification of opioid use disorder with opium tincture assisted treatment
by: Sahar Omidvar Tehrani, et al.
Published: (2023-12-01)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
by: Kevin Y Xu, et al.
Published: (2023-12-01)

Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series
by: Taylor A. Ochalek, et al.
Published: (2023-06-01)

Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series
by: Anthony Spadaro, et al.
Published: (2023-02-01)

Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder
by: Maja Radic, et al.
Published: (2022-06-01)

Guided Metabolic Detoxification Program Supports Phase II Detoxification Enzymes and Antioxidant Balance in Healthy Participants
by: Chinmayee Panda, et al.
Published: (2023-05-01)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine [version 2; peer review: 2 approved]
by: Alison Lynch, et al.
Published: (2023-08-01)

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
by: Hannah Ellerbroek, et al.
Published: (2022-09-01)